Rating History for Tarsus Pharmaceuticals (TARS) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/16/2026 | Glen Santangelo | New Coverage | Overweight (N/A) |
110.00 (N/A) |
79.95 (68.07) |
-14.86% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||



